- Teamwork. At Mayo Clinic, digestive disease specialists (gastroenterologists) work closely with liver experts (hepatologists), radiologists and pathologists to care for people with nonalcoholic fatty liver disease. Other professionals are included as needed.
- Expertise. Mayo Clinic doctors described and named this disease in 1980.
- Experience. Mayo Clinic doctors have cared for many people with nonalcoholic fatty liver disease, including those with minimal liver damage and those with very serious liver failure. Mayo Clinic doctors care for about 6,000 people with nonalcoholic fatty liver disease each year.
- A full range of treatment options to consider. Mayo Clinic doctors will work with you to review all of your treatment options and choose the treatment that best suits your needs and goals. A range of treatment options are available to you, depending on your specific situation. Treatments may include help making lifestyle changes, medications and surgical procedures, such as weight-loss surgery and liver transplant.
- Innovation. Mayo Clinic doctors and researchers have developed a noninvasive way to test for liver scarring. They hope this new technology, called magnetic resonance elastography, may one day reduce the need for liver biopsies in people with liver disease.
Mayo Clinic in Rochester, Minn., ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked high performing for digestive disorders by U.S. News & World Report.
American Liver Foundation: Support services
Jan. 02, 2014
- Non-alcoholic fatty liver disease (NAFLD). American College of Gastroenterology. http://patients.gi.org/topics/fatty-liver-disease-nafld. Accessed Sept. 26, 2013.
- Non-alcoholic fatty liver disease. American Liver Foundation. http://www.liverfoundation.org/abouttheliver/info/nafld. Accessed Sept. 26, 2013.
- Feldman M, et al. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2010. http://www.clinicalkey.com. Accessed Sept. 26, 2013.
- Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases and American College of Gastroenterology. Gastroenterology. 2012;142:1592.
- Molloy JW, et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis and degree of hepatic fibrosis. Hepatology. 2012;55:429.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. Aug. 16, 2013.
- Ludwig J, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings. 1980;55:434
- Venkatesh SK, et al. Magnetic resonance elastography of liver: Technique, analysis and clinical applications. Journal of Magnetic Resonance Imaging. 2013;37:544.
- ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older — United States, 2013. MMWR. 2013;62:13. http://www.cdc.gov/mmwr/preview/mmwrhtml/su6201a3.htm?s_cid=su6201a3_w. Accessed Oct. 11, 2013.